| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |